The critical role of IL-34 in osteoclastogenesis

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Chen, Zhi ^a   Buki, Kalman ^a   Vääräniemi, Jukka ^a   Gu, Guoliang ^a   Väänänen, H Kalervo ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CD11B ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 34; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG; INTERLEUKIN 34, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-34, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DISEASE; BONE MARROW CELL; BONE MASS; BONE METABOLISM; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG TARGETING; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION; SPLEEN CELL; TRABECULAR BONE; ANIMAL; BONE; BONE DEVELOPMENT; CELL COUNT; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; ORGAN SIZE; PATHOLOGY; SPLEEN;

MUS;

ANIMALS; BONE AND BONES; BONE MARROW CELLS; BONE RESORPTION; CELL COUNT; CELL DIFFERENTIATION; HUMANS; INTERLEUKINS; MICE; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND; SPLEEN;

EID: 79954465008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018689     Document Type: Article

References (29)

1. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (2): 165-176.
2. Teitelbaum SL, (2000) Bone resorption by osteoclasts. Science 289 (5484): 1504-1508.
3. Roodman GD, (2006) Regulation of osteoclast differentiation. Ann N Y Acad Sci 1068: 100-109.
4. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, et al. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (6717): 315-323.
5. Pearse RN, Sordillo EM, Yaccoby S, Wong BR, Liau DF, et al. (2001) Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A 98 (20): 11581-11586.
6. Sezer O, Heider U, Zavrski I, Kuhne CA, Hofbauer LC, (2003) RANK ligand and osteoprotegerin in myeloma bone disease. Blood 101 (6): 2094-2098.
7. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, et al. (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 (6274): 442-444.
8. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed-Ansari A, Sell KW, et al. (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A 87 (12): 4828-4832.
9. Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, et al. (1991) Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173 (1): 269-272.
10. Van Wesenbeeck L, Odgren PR, MacKay CA, D'Angelo M, Safadi FF, et al. (2002) The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc Natl Acad Sci U S A 99 (22): 14303-14308.
11. Kim N, Kadono Y, Takami M, Lee J, Lee SH, et al. (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202 (5): 589-595.
12. Li P, Schwarz EM, O'Keefe RJ, Ma L, Looney RJ, et al. (2004) Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum 50 (1): 265-276.
13. Yao Z, Li P, Zhang Q, Schwarz EM, Keng P, et al. (2006) Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem 281 (17): 11846-11855.
14. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL, (2005) IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115 (2): 282-290.
15. Kim JH, Jin HM, Kim K, Song I, Youn BU, et al. (2009) The mechanism of osteoclast differentiation induced by IL-1. J Immunol 183 (3): 1862-1870.
16. Yao Z, Xing L, Qin C, Schwarz EM, Boyce BF, (2008) Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism. J Biol Chem 283 (15): 9917-9924.
17. Blevins G, Fedoroff S, (1995) Microglia in colony-stimulating factor 1-deficient op/op mice. J Neurosci Res 40 (4): 535-544.
18. Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, et al. (2002) Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99 (1): 111-120.
19. Lin H, Lee E, Hestir K, Leo C, Huang M, et al. (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320 (5877): 807-811.
20. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, et al. (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (6759): 304-309.
21. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, et al. (1999) Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone 25 (5): 517-523.
22. Rodan GA, Martin TJ, (1981) Role of osteoblasts in hormonal control of bone resorption-a hypothesis. Calcif Tissue Int 33 (4): 349-351.
23. Mulari MT, Qu Q, Harkonen PL, Vaananen HK, (2004) Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro. Calcif Tissue Int 75 (3): 253-261.
24. Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, et al. (1997) Biology and action of colony-stimulating factor-1. Mol Reprod Dev 46 (1): 4-10.
25. Hamilton JA, (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8 (7): 533-544.
26. Baud'huin M, Renault R, Charrier C, Riet A, Moreau A, et al. (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol 221: 77-86.
27. Wei S, Nandi S, Chitu V, Yeung YG, Yu W, et al. (2010) Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J Leukoc Biol 88: 495-505.
28. Minkin C, (1982) Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34 (3): 285-290.
29. Selander K, Lehenkari P, Vaananen HK, (1994) The effects of bisphosphonates on the resorption cycle of isolated osteoclasts. Calcif Tissue Int 55 (5): 368-375.